Option chain shows key data for Pulmatrix's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Pulmatrix.

Pulmatrix (NASDAQ:PULM) Stock, Option Chain

Pulmatrix

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

Biotech

News

Penny Stocks

Health Care

Movers

Trading Ideas

General

PULM

Pulmatrix Says Formulated Inhaled Migraine Candidate Safe With Fewer GI Side Effects Compared To IV

Small Cap

Pre-Market Outlook

Markets

ADSK

AGFY

ALLR

ANPC

ATHX

BCAN

BGNE

FREY

JWEL

LODE

MOHO

NTAP

NVDA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

RERE

RVAC

SNOW

SPCB

SPLK

TCRT

VACC

VSCO

Gainers


	ECMOHO Limited (NASDAQ: MOHO) shares rose 47% to $0.2149 in pre-market trading.


Why Splunk Is Trading Lower By Around 10%; Here Are 28 Stocks Moving Premarket

Pulmatrix (NASDAQ: PULM) has dosed first subject in its Phase 1 trial evaluating PUR3100 for the treatment of acute migraine.

PUR3100 is an orally-inhaled Dihydroergotamine (DHE) acute migraine therapy.

Pulmatrix Commences Initial-Stage Acute Migraine Study

Pulmatrix Inc

Pulmonx Corp

Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) has outperformed the market over the past 5 years by 2.92% on an annualized basis producing an average annual return of 17.56%. Currently, Devon Energy has a market capitalization of $23.00 billion. 
Buying $1000 In DVN: If an investor had bought $1000 of DVN stock 5 years ago, it would be worth $2,174.13 today based on a price of $35.46 for DVN at the time of writing.
<h3>Devon Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740608124_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Devon Energy 5 Years Ago Would Be Worth Today

Carriage Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSV#NYSE">CSV</a>) is looking for FY2025 Adj EPS of $3.10-$3.30 vs $2.88 analyst estimate. sees sales of $400.000 million-$410.000 million vs $419.77 million analyst estimate.

Guidance

Carriage Servs Sees FY2025 Adj EPS $3.10-$3.30 vs $2.88 Est; Sees Sales $400.000M-$410.000M vs $419.77M Est

Carriage Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSV#NYSE">CSV</a>) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.51 by 21.57 percent. This is a 3.13 percent decrease over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $97.70 million which beat the analyst consensus estimate of $96.72 million by 1.01 percent. This is a 4.03 percent increase over sales of $93.92 million the same period last year.

Earnings

Earnings Beats

Carriage Servs Q4 Adj $0.62 Beats $0.51 Estimate, Sales $97.70M Beat $96.72M Estimate

WIIM

ARDT

Ardent Health Partners shares are trading higher after the company reported better-than-expected Q4 financial results.

Keurig Dr Pepper shares are trading lower after the company announced a secondary offering of common stock by JAB.

MARA

MARA Holdings shares are trading higher after the company reported better-than-expected Q4 financial results.

Sitio Royalties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STR#NYSE">STR</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.11 by 27.27 percent. This is a 93.85 percent decrease over earnings of $1.30 per share from the same period last year. The company reported quarterly sales of $155.10 million which beat the analyst consensus estimate of $145.60 million by 6.52 percent. This is a 3.85 percent increase over sales of $149.35 million the same period last year.

Earnings Misses

Sitio Royalties Q4 EPS $0.08 Misses $0.11 Estimate, Sales $155.10M Beat $145.60M Estimate

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific shares are trading higher after the company reported its Q4 financial results. The company announced it expanded its partnership with CoreWeave.

Ibotta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.45 by 48.89 percent. This is a 32.32 percent decrease over earnings of $0.99 per share from the same period last year. The company reported quarterly sales of $98.38 million which missed the analyst consensus estimate of $103.63 million by 5.06 percent. This is a 1.30 percent decrease over sales of $99.67 million the same period last year.

IBTA

Ibotta Q4 Adj EPS $0.67 Beats $0.45 Estimate, Sales $98.38M Miss $103.63M Estimate

Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRP#NYSE">GRP</a>) reported quarterly earnings of $0.89 per share This is a 5.8 percent increase over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $105.82 million. This is a 10.96 percent increase over sales of $95.37 million the same period last year.

Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc.

GRP/U

Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. Q4 AFFO $0.89, Sales $105.82M

Ovinitiv Sees Q1 Total Production (MBOE/d) 575-595.

The Allstate Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) announced that its board of directors approved a quarterly common stock dividend of $1.00 on Feb. 26, 2025, which is an increase of $0.08, or 8.7%, per share compared to last quarter. Allstate also declared the payment of quarterly preferred dividends.
In addition, the board of directors has authorized a $1.5 billion share repurchase program of outstanding common stock. The authorization will remain in effect through Sept. 30, 2026.

Dividends

Buybacks

Allstate Announces Quarterly Dividend Increase From $0.92 To $1.00 Per Share; Authorizes $1.5B Share Repurchase Program

Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $1.16 by 119.83 percent. This is a 109.79 percent decrease over earnings of $2.35 per share from the same period last year.

Ovintiv Q4 2024 Adj. EPS $(0.23) Misses $1.16 Estimate

CLEU

China Liberal Education Holdings shares are trading lower after the company announced the company plans to effect a share consolidation.

Seadrill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDRL#NYSE">SDRL</a>) reported quarterly earnings of $1.54 per share which beat the analyst consensus estimate of $(0.37) by 516.22 percent. This is a 62.11 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $289.000 million which missed the analyst consensus estimate of $296.918 million by 2.67 percent. This is a 29.17 percent decrease over sales of $408.000 million the same period last year.

SDRL

Seadrill Q4 2024 GAAP EPS $1.54 Beats $(0.37) Estimate, Sales $289.000M Miss $296.918M Estimate

Urgent.Ly shares are trading higher after the company announced it entered into a new credit agreement for an asset-based revolving credit facility for up to $20 million with MidCap Financial.

CHTR

LBRDA

LBRDK

LBRDP

Charter And Liberty Broadband Stockholders Approve Charter Acquisition Of Liberty Broadband

Financing

Urgently Enter Into New Credit Agreement For An Asset-Based Revolving Credit Facility For Up To $20M With MidCap Financial, Which Will Be Used To Repay Existing Indebtedness To Its First Lien Lenders

TSX Approves Nutrien Renewed Share Repurchase Program; Amount Not Disclosed

Universal Health Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHT#NYSE">UHT</a>) reported quarterly earnings of $0.34 per share. This is a 21.43 percent increase over earnings of $0.28 per share from the same period last year. The company reported $24.64 million in sales this quarter. This is a 1.32 percent increase over sales of $24.32 million the same period last year.

Universal Health Realty Q4 Adj $0.34 Up From $0.28 YoY, Sales $24.64M Up From $24.32M YoY

Legal

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

Kuehn Law Encourages ENTO, PULM, PIK, and PFC Investors to Contact Law Firm

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, LBRDA, ENTO, LLYVA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders

Kuehn Law Encourages BCOV, BERY, ROIC, and PULM Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, BERY, PULM on Behalf of Shareholders

Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders

Comments

Pulmatrix

Pulmatrix (PULM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga